Summary
This document is a report detailing the evolving landscape of drug development, emphasizing the role of data and evidence in clinical research. It outlines how the increasing complexity and cost of clinical trials necessitate efficient data management and innovative technologies. The report highlights the impact of big data, artificial intelligence (AI), and machine learning (ML) on drug discovery and clinical trials, noting their potential to enhance precision medicine and improve drug safety. It discusses the challenges faced by drug developers, including rising trial costs due to the need for more extensive data collection and the complexities of regulatory compliance. The report also presents insights from a survey of 150 leaders in the biotechnology and pharmaceutical sectors, focusing on trends and strategies for leveraging data in clinical development. Key considerations for maximizing data utility in clinical trials are included, emphasizing the importance of patient recruitment and the outsourcing of clinical data management to navigate the current challenges in the industry.
